These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36828801)

  • 21. Lipid-based nanomedicines for the treatment of bacterial respiratory infections: current state and new perspectives.
    Arroyo-Urea EM; Lázaro-Díez M; Garmendia J; Herranz F; González-Paredes A
    Nanomedicine (Lond); 2024 Feb; 19(4):325-343. PubMed ID: 38270350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current landscape in the discovery of novel antibacterial agents.
    Vila J; Moreno-Morales J; Ballesté-Delpierre C
    Clin Microbiol Infect; 2020 May; 26(5):596-603. PubMed ID: 31574341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Data Analytics Approach for Rational Design of Nanomedicines with Programmable Drug Release.
    Mullis AS; Broderick SR; Binnebose AM; Peroutka-Bigus N; Bellaire BH; Rajan K; Narasimhan B
    Mol Pharm; 2019 May; 16(5):1917-1928. PubMed ID: 30973741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sulfur and sulfur nanoparticles as potential antimicrobials: from traditional medicine to nanomedicine.
    Rai M; Ingle AP; Paralikar P
    Expert Rev Anti Infect Ther; 2016 Oct; 14(10):969-78. PubMed ID: 27494175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infection microenvironment-related antibacterial nanotherapeutic strategies.
    Wang Z; Liu X; Duan Y; Huang Y
    Biomaterials; 2022 Jan; 280():121249. PubMed ID: 34801252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Research progress of nanoparticle targeting delivery systems in bacterial infections.
    Jin M; He B; Cai X; Lei Z; Sun T
    Colloids Surf B Biointerfaces; 2023 Sep; 229():113444. PubMed ID: 37453264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. State-of-the-art polymeric nanoparticles as promising therapeutic tools against human bacterial infections.
    Cano A; Ettcheto M; Espina M; López-Machado A; Cajal Y; Rabanal F; Sánchez-López E; Camins A; García ML; Souto EB
    J Nanobiotechnology; 2020 Oct; 18(1):156. PubMed ID: 33129333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Future prospects of antibacterial metal nanoparticles as enzyme inhibitor.
    Ahmed KBA; Raman T; Veerappan A
    Mater Sci Eng C Mater Biol Appl; 2016 Nov; 68():939-947. PubMed ID: 27524096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell Membrane-Coated Nanoparticles As an Emerging Antibacterial Vaccine Platform.
    Angsantikul P; Thamphiwatana S; Gao W; Zhang L
    Vaccines (Basel); 2015 Oct; 3(4):814-28. PubMed ID: 26457720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanomedicine: novel approaches in human and veterinary therapeutics.
    Irache JM; Esparza I; Gamazo C; Agüeros M; Espuelas S
    Vet Parasitol; 2011 Aug; 180(1-2):47-71. PubMed ID: 21680101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting virulence not viability in the search for future antibacterials.
    Heras B; Scanlon MJ; Martin JL
    Br J Clin Pharmacol; 2015 Feb; 79(2):208-15. PubMed ID: 24552512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanomedicine to overcome antimicrobial resistance: challenges and prospects.
    Zou W; McAdorey A; Yan H; Chen W
    Nanomedicine (Lond); 2023 Feb; 18(5):471-484. PubMed ID: 37170884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intelligent Jellyfish-type Janus Nanoreactor Targeting Synergistic Treatment of Bacterial Infections.
    Huang Y; Liu D; Guo R; Wang B; Lu Y
    ACS Appl Bio Mater; 2023 Jun; 6(6):2384-2393. PubMed ID: 37191675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hybrid Nanosystems of Antibiotics with Metal Nanoparticles-Novel Antibacterial Agents.
    Shabatina TI; Vernaya OI; Melnikov MY
    Molecules; 2023 Feb; 28(4):. PubMed ID: 36838591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanomedicine as an emerging approach against intracellular pathogens.
    Armstead AL; Li B
    Int J Nanomedicine; 2011; 6():3281-93. PubMed ID: 22228996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic-nanomedicines: facing the challenge of effective treatment of antibiotic-resistant respiratory tract infections.
    Ritsema JA; der Weide HV; Te Welscher YM; Goessens WH; van Nostrum CF; Storm G; Bakker-Woudenberg IA; Hays JP
    Future Microbiol; 2018 Nov; 13():1683-1692. PubMed ID: 30499686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phage Display-Derived Peptides and Antibodies for Bacterial Infectious Diseases Therapy and Diagnosis.
    Zhao H; Nie D; Hu Y; Chen Z; Hou Z; Li M; Xue X
    Molecules; 2023 Mar; 28(6):. PubMed ID: 36985593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanomedicine for the Detection and Treatment of Ocular Bacterial Infections.
    Huang X; Li L; Chen Z; Yu H; You X; Kong N; Tao W; Zhou X; Huang J
    Adv Mater; 2023 Nov; 35(46):e2302431. PubMed ID: 37231939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanotechnology as a therapeutic tool to combat microbial resistance.
    Pelgrift RY; Friedman AJ
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1803-15. PubMed ID: 23892192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanovaccines to combat virus-related diseases.
    Wu F; Qin M; Wang H; Sun X
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Mar; 15(2):e1857. PubMed ID: 36184873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.